Synopsys Inc. (SNPS) Stock Analysis 2026

TechnologyElectronic Design Automation (EDA)
$384.97
as of 2026-09-18
-5.2% (52-week)50D MA $416.69  |  200D MA $446.85

BriMind AI Score

Proprietary
62
Moderate
Price CAGR
21.1%
1Y Return
-6.6%
Analyst Upside
+37.1%
Rev Growth
42.4%

Score based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.

AI scores and price targets are for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results. Always conduct your own research before making investment decisions. Full Disclaimer →

About Synopsys Inc.

Synopsys is the world's largest electronic design automation (EDA) company by revenue, alongside Cadence the essential provider of software tools for designing semiconductors. Synopsys dominates synthesis and timing (converting chip designs into actual transistor layouts) and is a leader in chip simulation, formal verification, and hardware security testing. The company is acquiring Ansys (computational simulation software) in a $35B deal that would expand Synopsys from chip-level EDA into broader engineering simulation for aerospace, automotive, and industrial applications.

How Synopsys Makes Money

Synopsys earns through subscription licenses for EDA tools, IP licensing (standardized semiconductor IP blocks that chip designers incorporate), and software integrity/security tools (Coverity, Black Duck — testing software for security vulnerabilities). Revenue is highly recurring, with 80%+ from multi-year subscription contracts. The Ansys acquisition (pending regulatory approval) would add significant mechanical, fluid, and electromagnetic simulation revenue.

Synopsys Revenue & Profitability Breakdown

This chart shows how Synopsys's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.

Revenue
$9.42B
Cost of Revenue
-$1.61B
Gross Profit
$7.81B82.9% margin
Operating Expenses
-$6.44B
Operating Income
$1.37B14.5% margin
Tax & Other
-$290.8M
Net Income
$1.08B11.4% margin
Gross Margin
82.9%
Operating Margin
14.5%
Net Margin
11.4%
EBITDA Margin
23.7%

Key Financial Metrics

Synopsys Inc. trades at a trailing P/E of 77.51x, generates $3.43B in free cash flow, runs a debt/equity ratio of 34.80, and converts shareholder equity into profit at a 3.7% return on equity. For context: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business; Debt/Equity shows how leveraged a company is; Return on Equity shows how efficiently it turns shareholder capital into profit.

Market Cap
$84.82B
Enterprise Value
$71.89B
P/E (Trailing)
77.51
P/E (Forward)
25.28
PEG Ratio
2.33
EV / EBITDA
48.84
Price / Sales
12.12
Price / Book
7.60
Revenue
$9.42B
Revenue Growth
42.4%
Earnings Growth
89.3%
EBITDA
$1.47B
Gross Margin
82.9%
Operating Margin
14.5%
Net Margin
11.4%
Return on Equity
3.7%
Return on Assets
1.4%
Free Cash Flow
$3.43B
Total Cash
$14.26B
Total Debt
$10.74B
Debt / Equity
34.80
Current Ratio
1.34
Quick Ratio
1.17
Beta
1.21
Dividend Yield
None
Payout Ratio
0.0%
Insider Ownership
3.0%
Inst. Ownership
93.2%
Short % Float
2.3%
Book Value / Share
$162.59

Wall Street Analyst Consensus

23 analysts covering Synopsys Inc. currently lean toward a Strong Buy rating, with a mean 12-month price target of $544.97 (+41.6% vs the current price). Analysts set these targets after researching a company's earnings, competitive position, and industry trends — Strong Buy / Buy means the majority expect meaningful upside, while Hold means fair value near the current price rather than a sell signal.

Consensus RatingStrong Buy(23 analysts)
SellStrong Buy
Low Target$502.4130.5%
Mean Target$544.97+41.6% upside
High Target$685.00+77.9%

Intrinsic Value Estimates for SNPS

We use 1 valuation model to estimate SNPS's intrinsic value. Intrinsic value is what a stock is truly worth based on the company's fundamentals, independent of what the market prices it at today. If multiple models agree the stock is undervalued, that convergence is a stronger signal.

Technical Price Signals

SNPS is currently in a death cross pattern, trading below its 50-day average of $416.69 and below its 200-day average of $446.85. Moving averages smooth out day-to-day volatility to reveal the underlying trend — a Golden Cross (50MA crosses above 200MA) is a classic bullish signal, a Death Cross is bearish, though both are lagging indicators that confirm trends rather than predict them.

Current Price
$384.97
50-Day MA
$416.69
▼ Price below
200-Day MA
$446.85
▼ Price below
Death Cross Pattern
Price below both MAs — bearish signal

SNPS Investment Case: Bull vs Bear

SNPS's investment case breaks down into 4 bull points and 4 bear points below. The bull case outlines the key reasons the stock could outperform — competitive advantages, growth catalysts, and market tailwinds. The bear case highlights the most significant risks. A strong bull case with manageable bear risks typically makes for a more compelling investment.

Bull Case (Reasons to Buy)

  • Synopsys-Ansys combination would create the world's dominant engineering simulation platform — covering everything from chip-level EDA to system-level aerospace and automotive simulation.
  • AI chip complexity is growing every year — NVIDIA's Blackwell and next-generation AI accelerators require more verification and simulation steps, directly expanding Synopsys tool usage.
  • DSO.ai (Design Space Optimization) — Synopsys's AI-powered chip design tool — demonstrates the ability to find chip designs that outperform human engineers in power and area.
  • Software security (Coverity, Black Duck) is a fast-growing segment as software supply chain security becomes a mandatory enterprise and government priority.

Bear Case (Key Risks)

  • Ansys acquisition regulatory risk: the EU and UK have examined the merger carefully given concerns about combined simulation monopoly power — deal termination risk remains.
  • EDA market cyclicality: semiconductor design activity follows chip industry cycles — design slowdowns reduce tool utilization and slow subscription growth.
  • Competition from Cadence is intense in every major EDA segment — both companies invest heavily in R&D to maintain relative tool quality parity.
  • Valuation at 45-55x forward earnings requires the Ansys deal closing and continued semiconductor design activity growth.

What to Watch: SNPS Key Metrics

EDA product revenue growth
Ansys merger regulatory approval timeline
AI tool (DSO.ai) adoption
Software Integrity revenue growth
Operating margin

SNPS Stock — Frequently Asked Questions

Read the full SNPS in-depth report
Seven-method valuation, AI Score, blended price target, and a 5-year Monte Carlo simulation for Synopsys Inc..

Compare SNPS with Peers

CDNS vs SNPSCadence vs Synopsys — the EDA duopoly compared
MSFT vs SNPSMicrosoft vs Synopsys — Cloud & AI Giant vs Chip Design
ORCL vs SNPSOracle vs Synopsys — Cloud Database Giant vs Chip Desig

Unlock the Full SNPS Analysis

Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 14-day free trial — no credit card required.

Start Free TrialBrowse All Stocks
Data sources: Financial metrics and market data sourced from company SEC filings, earnings releases, and investor relations disclosures. Price data, analyst consensus targets, and fundamental financials provided by financial market data providers. ETF data sourced from official fund prospectuses and index provider publications. AI scores and price targets are proprietary estimates — see our Methodology and Disclaimer for details.
← Back to Home · Browse All Stock Analysis